In vitro assessment of metabolic drug–drug interaction potential of AZD2624, neurokinin-3 receptor antagonist, through cytochrome P₄₅₀ enzyme identification, inhibition, and induction studies

By Li Yan   Zhou Diansong   Ferguson Stephen S.   Dorff Peter   Simpson Thomas R.   Grimm Scott W.  

Xenobiotica, Vol. 40, Iss. 11, 2010-11 ,pp. : 721-729

Informa Healthcare

Access to resources Recommend Favorite

In vitro and in vivo metabolism of a novel cannabinoid-1 receptor inverse agonist, taranabant, in rats and monkeys

By Reddy V.B.G.   Doss G.A.   Karanam B.V.   Samuel K.   Lanza Jr T.J.   Lin L.S.   Yu N.X.   Zhang A.S.   Raab C.E.   Stearns R.A.   Kumar S.  

Xenobiotica, Vol. 40, Iss. 9, 2010-09 ,pp. : 650-662

Informa Healthcare

Access to resources Recommend Favorite

In vitro mammalian metabolism of the mitosis inhibitor zoxamide and the relationship to its In vitro toxicity

By Oesch F.   Metzler M.   Fabian E.   Kamp H.   Bernshausen T.   Damm G.   Triebel S.   Döhmer J.   Landsiedel R.   Van Ravenzwaay B.  

Xenobiotica, Vol. 40, Iss. 1, 2010-01 ,pp. : 72-82

Informa Healthcare

Access to resources Recommend Favorite

Identification of the human cytochrome P450s responsible for the in vitro metabolism of a leukotriene B4 receptor antagonist, CP-195,543

By Khojasteh-Bakht S. C.   Rossulek M. I.   Fouda H. G.   Prakash C.  

Xenobiotica, Vol. 33, Iss. 12, 2003-12 ,pp. : 1201-1210

Informa Healthcare

Access to resources Recommend Favorite

Antioxidant properties of fungal metabolite nigerloxin in vitro

By Suresha B.   Srinivasan K.  

Applied Biochemistry and Microbiology, Vol. 49, Iss. 6, 2013-11 ,pp. : 587-591

MAIK Nauka/Interperiodica

Access to resources Recommend Favorite